These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8788469)
1. Modulation of the A10 dopamine system: electrophysiological studies of the role of 5-HT3-like receptors. Wang RY; Ashby CR; Zhang JY Behav Brain Res; 1996; 73(1-2):7-10. PubMed ID: 8788469 [TBL] [Abstract][Full Text] [Related]
2. The role of 5-HT3-like receptors in the action of clozapine. Wang RY; Ashby CR; Edwards E; Zhang JY J Clin Psychiatry; 1994 Sep; 55 Suppl B():23-6. PubMed ID: 7961566 [TBL] [Abstract][Full Text] [Related]
3. The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin. Edwards E; Ashby CR; Wang RY Brain Res; 1991 Apr; 545(1-2):276-8. PubMed ID: 1677603 [TBL] [Abstract][Full Text] [Related]
4. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors. Squires RF; Saederup E Neurochem Res; 1999 May; 24(5):659-67. PubMed ID: 10344595 [TBL] [Abstract][Full Text] [Related]
5. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study. Bergqvist PB; Dong J; Blier P Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084 [TBL] [Abstract][Full Text] [Related]
6. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Wang RY; Liang X Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579 [TBL] [Abstract][Full Text] [Related]
7. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats. Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence. Ninan I; Wang RY Eur J Neurosci; 2003 Mar; 17(6):1306-12. PubMed ID: 12670320 [TBL] [Abstract][Full Text] [Related]
9. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666 [TBL] [Abstract][Full Text] [Related]
10. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Deutch AY; Duman RS Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147 [TBL] [Abstract][Full Text] [Related]
11. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action. Di Pietro NC; Seamans JK Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940 [TBL] [Abstract][Full Text] [Related]
12. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Willins DL; Berry SA; Alsayegh L; Backstrom JR; Sanders-Bush E; Friedman L; Roth BL Neuroscience; 1999; 91(2):599-606. PubMed ID: 10366017 [TBL] [Abstract][Full Text] [Related]
13. Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Rollema H; Lu Y; Schmidt AW; Zorn SH Eur J Pharmacol; 1997 Nov; 338(2):R3-5. PubMed ID: 9456005 [TBL] [Abstract][Full Text] [Related]
14. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats. Morrow BA; Rosenberg SJ; Roth RH Synapse; 1999 Oct; 34(1):28-35. PubMed ID: 10459169 [TBL] [Abstract][Full Text] [Related]
15. Role of serotonin in the action of atypical antipsychotic drugs. Meltzer HY Clin Neurosci; 1995; 3(2):64-75. PubMed ID: 7583621 [TBL] [Abstract][Full Text] [Related]
16. Functional antagonistic properties of clozapine at the 5-HT3 receptor. Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717 [TBL] [Abstract][Full Text] [Related]
17. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Ward RP; Dorsa DM Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms. Prus AJ; Baker LE; Meltzer HY Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446 [TBL] [Abstract][Full Text] [Related]
19. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. López-Gil X; Artigas F; Adell A Curr Pharm Des; 2010; 16(5):502-15. PubMed ID: 19909228 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Westerink BH; Kawahara Y; De Boer P; Geels C; De Vries JB; Wikström HV; Van Kalkeren A; Van Vliet B; Kruse CG; Long SK Eur J Pharmacol; 2001 Jan; 412(2):127-38. PubMed ID: 11165224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]